Cargando…

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates

SIMPLE SUMMARY: The purpose of this review is to provide an update on some of the most promising non-oncology drugs that are already approved and that could be useful also in the treatment of pancreatic cancer, one of the deadliest malignancies worldwide. Current chemotherapy options are unsatisfact...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Lellis, Laura, Veschi, Serena, Tinari, Nicola, Mokini, Zhirajr, Carradori, Simone, Brocco, Davide, Florio, Rosalba, Grassadonia, Antonino, Cama, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394389/ https://www.ncbi.nlm.nih.gov/pubmed/34439102 http://dx.doi.org/10.3390/cancers13163946

Ejemplares similares

The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
por: Brocco, Davide, et al.
Publicado: (2020)

Exosomes as Pleiotropic Players in Pancreatic Cancer
por: De Lellis, Laura, et al.
Publicado: (2021)

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
por: Florio, Rosalba, et al.
Publicado: (2019)

Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
por: Florio, Rosalba, et al.
Publicado: (2021)

Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents
por: Veschi, Serena, et al.
Publicado: (2020)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
por: Veschi, Serena, et al.
Publicado: (2018)

Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2022)

Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer?
por: Mokini, Zhirajr, et al.
Publicado: (2022)

Prognostic value of gender and primary tumor location in metastatic colon cancer
por: Grassadonia, Antonino, et al.
Publicado: (2023)

Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors
por: Brocco, Davide, et al.
Publicado: (2021)

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer
por: Brocco, Davide, et al.
Publicado: (2022)

High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study
por: Brocco, Davide, et al.
Publicado: (2022)

Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells
por: Florio, Rosalba, et al.
Publicado: (2023)

Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol
por: Catitti, Giulia, et al.
Publicado: (2022)

Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
por: Veschi, Serena, et al.
Publicado: (2020)

CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy
por: Pagotto, Sara, et al.
Publicado: (2023)

Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression
por: Grassadonia, Antonino, et al.
Publicado: (2021)

Correction: Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression
por: Grassadonia, Antonino, et al.
Publicado: (2021)

Metoclopramide and Propofol to Prevent Nausea and Vomiting during Cesarean Section under Spinal Anesthesia: A Randomized, Placebo-Controlled, Double-Blind Trial
por: Mokini, Zhirajr, et al.
Publicado: (2021)

Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer
por: Di Marino, Pietro, et al.
Publicado: (2022)

Breast Cancer “Tailored Follow-up” in Italian Oncology Units: A Web-Based Survey
por: Natoli, Clara, et al.
Publicado: (2014)

Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells
por: Florio, Rosalba, et al.
Publicado: (2018)

Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies
por: Ammazzalorso, Alessandra, et al.
Publicado: (2020)

Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2013)

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
por: Grassadonia, Antonino, et al.
Publicado: (2018)

Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates
por: Cybula, Magdalena, et al.
Publicado: (2022)

Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure–Activity Relationship Studies and Target Prediction Analysis
por: Amoroso, Rosa, et al.
Publicado: (2022)

Low AMY1 Gene Copy Number Is Associated with Increased Body Mass Index in Prepubertal Boys
por: Marcovecchio, M. Loredana, et al.
Publicado: (2016)

Recurrence Kinetics after Laparoscopic Versus Open Surgery in Colon Cancer. A Meta-Analysis
por: Lilley, Ross, et al.
Publicado: (2021)

Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants
por: LATTANZIO, ROSSANO, et al.
Publicado: (2016)

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib
por: Di Marino, Pietro, et al.
Publicado: (2020)

Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review
por: Grassadonia, Antonino, et al.
Publicado: (2015)

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression
por: Peri, Marta, et al.
Publicado: (2019)

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review
por: Sperduti, Isabella, et al.
Publicado: (2013)

Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing
por: ZHANG, QI, et al.
Publicado: (2016)

The updated landscape of tumor microenvironment and drug repurposing
por: Jin, Ming-Zhu, et al.
Publicado: (2020)

Metformin: update on mechanisms of action and repurposing potential
por: Foretz, Marc, et al.
Publicado: (2023)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
por: Lunardi, Serena, et al.
Publicado: (2015)

Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy
por: Mao, Xia, et al.
Publicado: (2023)

Integrative Analysis of Hereditary Nonpolyposis Colorectal Cancer: the Contribution of Allele-Specific Expression and Other Assays to Diagnostic Algorithms
por: De Lellis, Laura, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9qf4ebarmptvshpf7hjt02mm5r